Tromantadin

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

IndicationThis section has been translated automatically.

Herpes simplex infections of the skin and transitional mucous membranes.

Notice!

Controversial therapeutic principle!

Limited indicationThis section has been translated automatically.

Pregnancy, nursing.

Standard concentrationThis section has been translated automatically.

Apply 1% as a cream or gel 3-5 times/day thinly to the infected and neighbouring skin areas.

Notice! Stop treatment if there is no improvement within 2 days!

Undesirable effectsThis section has been translated automatically.

Frequent allergic reaction, paragroup allergy (gel).

InteractionsThis section has been translated automatically.

Cross-allergy to amantadine.

ContraindicationThis section has been translated automatically.

Paragroup allergy (gel).

PreparationsThis section has been translated automatically.

Viru-Merz

Authors

Last updated on: 29.10.2020